Skip to main content
. 2022 Nov 2;57(Suppl 1):100–416. doi: 10.1038/s41409-022-01798-0
Baseline renal impairment Maribavir
% (n/N)
IAT
% (n/N)
Adjusted difference in proportion of responders
% (95% CI)
None 56.8 (46/81) 25.6 (10/39) 32.3 (14.47, 50.11)
Mild 47.9 (34/71) 26.2 (11/42) 21.6 (3.77, 39.39)
Moderate 68.3 (41/60) 18.2 (4/22) 49.7 (29.83, 69.51)
Severe 37.5 (3/8) 0.0 (0/3)
Missing 46.7 (7/15) 27.3 (3/11) 15.3 (−20.93, 51.48)